Intervention

AVENIO ctDNA Surveillance Kit

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting1

Common conditions7

Lead sponsors shown1

Clinical trials

2 shown

Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLCNCT04585490 · 2021-08-25

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)NCT04585477 · 2021-04-08

Common conditions

Non Small Cell Lung Cancer1 Non-small Cell Lung Cancer1 Non-small Cell Lung Cancer Stage I1 Non-small Cell Lung Cancer Stage II1 Non-small Cell Lung Cancer Stage III1 Nsclc1 NSCLC, Stage III1

Leading sponsors

Stanford University2

Trial status mix

RECRUITING1

SUSPENDED1

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.